Immuno Oncology Market by 2022- A Global Forecast
World’s one of the biggest and liable market research resource, Research and Markets recently published Immuno-Oncology Market, By Type and
Read moreWorld’s one of the biggest and liable market research resource, Research and Markets recently published Immuno-Oncology Market, By Type and
Read moreEuropean Commission (EC) provided marketing authorization for Amgen’s Kyprolis® (carfilzomib) in combo with lenalidomide and dexamethasone for the therapy of
Read moreTHOUSAND OAKS, California: The Morgan Stanley Global Healthcare Conference scheduled for Tuesday, Sept. 13, 2011 at the Grand Hyatt in
Read moreAmgen’s second quarter product sales for 2011 saw a spike of 8% to $3.9 billion. The adjusted and GAAP Earnings
Read more